0001423173-12-000002.txt : 20120320 0001423173-12-000002.hdr.sgml : 20120320 20120319181553 ACCESSION NUMBER: 0001423173-12-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120320 DATE AS OF CHANGE: 20120319 EFFECTIVENESS DATE: 20120320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROPHAGE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001423173 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-175217 FILM NUMBER: 12701733 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET, SUITE 3120 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 1-617-714-5468 MAIL ADDRESS: STREET 1: 222 THIRD STREET, SUITE 3120 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0704 D LIVE 0001423173 NEUROPHAGE PHARMACEUTICALS INC 222 THIRD STREET, SUITE 3120 CAMBRIDGE MA MASSACHUSETTS 02142 1-617-714-5468 DELAWARE None None Corporation true Hampus Hillerstrom c/o Neurophage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Vicki Sato c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Jonathan Solomon c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Paul Goldenheim c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Valerie Calenda c/o NeuroPhage Pharmaceuticals, Inc. 222 Third Street, Suite 3120 Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06 false 2012-03-02 false true true true false 0 9003644 9003644 0 false 31 0 0 0 false NEUROPHAGE PHARMACEUTICALS INC /s/ Hampus Hillerstrom Hampus Hillerstrom Executive Vice President 2012-03-19